In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evalve, Mitralign Deals: Heart Valves Draw New Device Investors

Executive Summary

Over the last few years, interventional heart valve technologies have been among the most popular segments of the cardiovascular device market with venture investors. This popularity has resulted in some VCs concluding that the space has become saturated. While the market may be getting tougher to enter for newcomers, the successful financing rounds recently closed by Evalve and Mitralign show that investors--including new device investors--remain bullish on companies that can demonstrate an effective percutaneous alternative to existing surgical procedures.
Advertisement

Related Content

Proving Device Incubation Works: An Interview with The Foundry
Abbott Moves into Heart Valves with Evalve Deal
Percutaneous Heart Valve Technology: The Mitral Challenge
Market & Industry Briefs
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007
Water Street: Finding a Middle-Market PE Niche
ValveXchange Inc.
Start-Up News October 2007
Evalve: Leading the Valve Revolution
Mitralign Inc.

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002880

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel